Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes.

CONCLUSION: Sofosbuvir-based regimens are effective to treat HCV in patients with CKD. In patients with mild CKD this type of therapy seems to be safe.
PMID: 31760038 [PubMed - as supplied by publisher]

Source: Braz J Infect Dis - November 20, 2019 Category: Infectious Diseases Authors: Rossato G, Tovo CV, Almeida PRL Tags: Braz J Infect Dis Source Type: research